Evidence mapPaperPMID 39703864Full record

ArticleFrontiers in endocrinology2024

Loss of Sult1a1 reduces body weight and increases browning of white adipose tissue.

Margherita Springer, Emmanuelle Meugnier, Katharina Schnabl, Kevin Sebastiaan Hof, Marie-France Champy, Tania Sorg, Benoit Petit-Demoulière, Natacha Germain, Bogdan Galusca, Bruno Estour and 3 more

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Margherita SpringerSociété des Produits Nestlé S.A., Nestlé Institute of Health Sciences, Lausanne, Switzerland.
Emmanuelle MeugnierUniv-Lyon, CarMeN Laboratory, Inserm U1060, INRAE U1397, Université Claude Bernard Lyon 1, Institut National des Sciences Appliquées de Lyon (INSA Lyon), Oullins, France.
Katharina SchnablChair for Molecular Nutritional Medicine, Technical University of Munich (TUM) School of Life Sciences, Technical University of Munich, Freising, Germany.
Kevin Sebastiaan HofMaven Health, Zürich, Switzerland.
Marie-France ChampyFrench National Infrastructure for Mouse Phenogenomics (PHENOMIN)-Institut Clinique de la Souris, Creation, Breeding, Phenotyping, Distribution and Archiving of Model Organisms (CELPHEDIA), National Centre for Scientific Research (CNRS), National Institute of Health and Medical Research (INSERM), Université de Strasbourg, Illkirch-Grafenstaden, France.
Tania SorgFrench National Infrastructure for Mouse Phenogenomics (PHENOMIN)-Institut Clinique de la Souris, Creation, Breeding, Phenotyping, Distribution and Archiving of Model Organisms (CELPHEDIA), National Centre for Scientific Research (CNRS), National Institute of Health and Medical Research (INSERM), Université de Strasbourg, Illkirch-Grafenstaden, France.
Benoit Petit-DemoulièreFrench National Infrastructure for Mouse Phenogenomics (PHENOMIN)-Institut Clinique de la Souris, Creation, Breeding, Phenotyping, Distribution and Archiving of Model Organisms (CELPHEDIA), National Centre for Scientific Research (CNRS), National Institute of Health and Medical Research (INSERM), Université de Strasbourg, Illkirch-Grafenstaden, France.
Natacha GermainDivision of Endocrinology, Centre Hospitalier Universitaire de Saint-Étienne, Saint-Etienne, France.
Bogdan GaluscaDivision of Endocrinology, Centre Hospitalier Universitaire de Saint-Étienne, Saint-Etienne, France.
Bruno EstourDivision of Endocrinology, Centre Hospitalier Universitaire de Saint-Étienne, Saint-Etienne, France.
Hubert VidalUniv-Lyon, CarMeN Laboratory, Inserm U1060, INRAE U1397, Université Claude Bernard Lyon 1, Institut National des Sciences Appliquées de Lyon (INSA Lyon), Oullins, France.
Martin KlingensporChair for Molecular Nutritional Medicine, Technical University of Munich (TUM) School of Life Sciences, Technical University of Munich, Freising, Germany.
Jörg HagerSociété des Produits Nestlé S.A., Nestlé Institute of Health Sciences, Lausanne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and objective: Overweight and obesity affects millions of individuals worldwide and consequently represents a major public health concern. Individuals living with overweight and obesity have difficulty maintaining a low body weight due to known physiological mechanisms which prevent further weight loss and drive weight regain. In contrast, mechanisms which promote low body weight maintenance receive less attention and are largely unknown. To uncover these intrinsic mechanisms, we investigated a human cohort of constitutionally thin (CT) individuals which maintain a low body weight and are resistant to weight gain despite exposure to an obesogenic environment. Methods: To identify novel genes that contribute to low body weight maintenance, we performed transcriptomics on adipose tissue biopsies collected from CT and normal body weight (NBW) individuals and identified sulfotransferase 1A1 (SULT1A1) as a target for further investigation in mice. Sult1a1 knockout (KO) mice were fed a standard diet to assess the impact of Sult1a1 deletion on metabolic traits. To determine if high-fat feeding recapitulated the CT weight gain resistance phenotype, Sult1a1 KO mice were fed a high-fat diet for 13-weeks. A subset of wild-type and Sult1a1 KO mice from the standard diet were further analyzed for characterization of adipose tissue respiratory capacity. Results: In comparison to NBW controls, adipose tissue from CT individuals expresses less SULT1A1. Sult1a1 KO mice weigh 10% less at the end of the study period and on a high-fat diet, Sult1a1 KO mice tended to gain less weight and had reduced fat mass at 14-weeks of age. These changes were associated with reduced fasting insulin and lessened adipose tissue inflammation and fibrosis. Subcutaneous adipose tissue from Sult1a1 KO mice on a standard chow diet had elevated leak respiration, uncoupling protein 1 (UCP1) expression and increased expression of a mitochondrial marker, VDAC, associating Sult1a1 deletion to adipose tissue browning. Conclusions: Our results associate Sult1a1 deletion with a tendency for lower body weight through remodeling of white adipose tissue towards a brown phenotype. The presence of UCP1, the expression of an additional mitochondrial protein and increased respiratory capacity suggest browning of the subcutaneous adipose tissue depot of Sult1a1 KO mice.

Indexed as

Adipose Tissue, BrownAdipose Tissue, WhiteArylsulfotransferaseBody WeightDiet, High-FatMice, KnockoutAdultAnimalsFemaleHumansMaleMiceMice, Inbred C57BLMiddle AgedObesityArylsulfotransferaseSULT1A1 protein, humanSult1a1 protein, mousebrowningleannessobesitysulfotransferase 1A1white adipose tissue

Identifiers

PMID39703864
PMCPMC11656314

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.